# Safety and Effectiveness Study of EverFlex Stent to Treat Symptomatic Femoral-popliteal Atherosclerosis

> **NCT00530712** · NA · COMPLETED · sponsor: **Medtronic Endovascular** · enrollment: 287 (actual)

## Conditions studied

- Peripheral Vascular Diseases
- Claudication

## Interventions

- **DEVICE:** PROTÉGÉ® EverFlex™ Self-Expanding Stent System

## Key facts

- **NCT ID:** NCT00530712
- **Lead sponsor:** Medtronic Endovascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2012-03
- **Final completion:** 2013-07
- **Target enrollment:** 287 (ACTUAL)
- **Last updated:** 2019-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00530712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00530712, "Safety and Effectiveness Study of EverFlex Stent to Treat Symptomatic Femoral-popliteal Atherosclerosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00530712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*